H
ALXN

Hexavest’s Alexion Pharmaceuticals ALXN Stock Holding History

Hexavest’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,552
Closed -$836K – 311
2021
Q2 		$836K Buy
4,552
+3,802
+507% +$653K 0.04% 191
2021
Q1 		$115K Buy
750
+689
+1,130% +$107K 0.01% 275
2020
Q4 		$10K Hold
61
– – ﹤0.01% 337
2020
Q3 		$7K Hold
61
– – ﹤0.01% 386
2020
Q2 		$7K Buy
+61
New +$6.48K ﹤0.01% 395
2019
Q4 		– Sell
-77
Closed -$8K – 498
2019
Q3 		$8K Hold
77
– – ﹤0.01% 488
2019
Q2 		$10K Buy
+77
New +$9.92K ﹤0.01% 491

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Hexavest's ALXN Position: Q3 2021 in Review

Hexavest sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 4,552 shares — an estimated $836K sold.

Hexavest first reported a position in ALXN in Q2 2019 and held it in 7 quarters. The position peaked at $836K in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Hexavest reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Hexavest sold 4,552 Alexion Pharmaceuticals shares in Q3 2021, an estimated $836K.
  • Hexavest first reported a position in Alexion Pharmaceuticals in Q2 2019 and held it in 7 quarters.
  • Hexavest's Alexion Pharmaceuticals position peaked at $836K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Hexavest's 13F filing for Q3 2021, filed 27 Oct 2021.